20-bromo-16,16-dimethyl-eicosa-5,8,11,14-all-cis-tetraenoic acid methyl ester | 322399-57-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 20-bromo-16,16-dimethyl-eicosa-5,8,11,14-all-cis-tetraenoic acid methyl ester
• 英文别名: methyl (5Z,8Z,11Z,14Z)-20-bromo-16,16-dimethylicosa-5,8,11,14-tetraenoate
• CAS: 322399-57-5
• 化学式: C₂₃H₃₇BrO₂
• 分子量: 425.45
• InChiKey: PJGLOCJREKFKQL-HKJQUKNWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.3
• 重原子数：
  26
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  20-bromo-16,16-dimethyl-eicosa-5,8,11,14-all-cis-tetraenoic acid methyl ester 在 lithium hydroxide 作用下， 以 甲醇 为溶剂， 以94%的产率得到(5Z,8Z,11Z,14Z)-20-bromo-16,16-dimethylicosa-5,8,11,14-tetraenoic acid
  参考文献：
  名称：

  The Synthesis of N-Vanillyl-arachidonoyl-amide (Arvanil) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate

  摘要：

  Several arvanil analogs were synthesized where the end n-pentyl chain was branched and carried substituents at the terminal end of the chain. A high yielding total synthesis of these analogs was developed from methyl hex-5-ynoate, which was converted to the synthon 6 in a facile five strip sequence (overall yield, 33%). The pharmacological profile of these novel analogs suggests that they may be acting through a novel site of action for anandamide (arachidonylethanolamide, AEA). (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(00)00877-2
• 作为产物：
  描述：

  (5Z,8Z,11Z)-14-Iodo-tetradeca-5,8,11-trienoic acid methyl ester 在 溴 、 sodium hexamethyldisilazane 、 三苯基膦 作用下， 以 四氢呋喃 、 六甲基磷酰三胺 、 二氯甲烷 、 乙腈 为溶剂， 反应 2.5h， 生成 20-bromo-16,16-dimethyl-eicosa-5,8,11,14-all-cis-tetraenoic acid methyl ester
  参考文献：
  名称：

  The Synthesis of N-Vanillyl-arachidonoyl-amide (Arvanil) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate

  摘要：

  Several arvanil analogs were synthesized where the end n-pentyl chain was branched and carried substituents at the terminal end of the chain. A high yielding total synthesis of these analogs was developed from methyl hex-5-ynoate, which was converted to the synthon 6 in a facile five strip sequence (overall yield, 33%). The pharmacological profile of these novel analogs suggests that they may be acting through a novel site of action for anandamide (arachidonylethanolamide, AEA). (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(00)00877-2

文献信息

• Novel eicosanoid analgesics
  申请人：——

  公开号：US20040122089A1

  公开（公告）日：2004-06-24

  Analogs of andandamide and arvanil have been found to act preferential at CB 1 and AR 1 receptors, and at receptors other than CB 1 and AR 1 . The analogs provide analgesic effects in vivo, and are useful in pain management. In addition, the analogs may be used as anti-proliferative/anti-tumor agents, vasodilators, and in other applications. Several of the anandamide and arvanil analogs are more potent than anandamide and arvanil.

  已发现与anandamide和arvanil类似物作用于CB1和AR1受体时具有优先性，并且还作用于非CB1和AR1受体。这些类似物在体内提供镇痛效果，并在疼痛管理中有用。此外，这些类似物还可以用作抗增殖/抗肿瘤剂、血管扩张剂以及其他应用。几种anandamide和arvanil类似物比anandamide和arvanil更有效。
• The Synthesis of N-Vanillyl-arachidonoyl-amide (Arvanil) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate
  作者：Olivier Dasse、Anu Mahadevan、Luning Han、Billy R. Martin、Vincenzo Di Marzo、Raj K. Razdan

  DOI：10.1016/s0040-4020(00)00877-2

  日期：2000.11

  Several arvanil analogs were synthesized where the end n-pentyl chain was branched and carried substituents at the terminal end of the chain. A high yielding total synthesis of these analogs was developed from methyl hex-5-ynoate, which was converted to the synthon 6 in a facile five strip sequence (overall yield, 33%). The pharmacological profile of these novel analogs suggests that they may be acting through a novel site of action for anandamide (arachidonylethanolamide, AEA). (C) 2000 Elsevier Science Ltd. All rights reserved.